INFLUENCE OF BIFIDOBACTERIUM TRIPLE VIABLE ADJUVANT TREATMENT ON NEONATAL JAUNDICE MANAGEMENT: CONNECTING SERUM BILIRUBIN REDUCTION TO FUTURE ATHLETIC PERFORMANCE

Abstract

Objective: To explore the impact of Bifidobacterium triple viable adjuvant treatment on neonatal jaundice outcomes, focusing on serum bilirubin levels, transcutaneous bilirubin index, and potential long-term effects on mental and physical health, including implications for future athletic performance and sports psychology. Methods: This study included 180 neonatal jaundice cases treated at our hospital from January 2018 to August 2020, randomly assigned to a control group (n=90) receiving standard blue light therapy, and a study group (n=90) receiving both blue light therapy and Bifidobacterium triple viable adjuvant treatment. We compared serum bilirubin levels, transcutaneous bilirubin indices, adverse reactions, and potential implications for long-term mental and physical health outcomes between the two groups. Results: Post-treatment, both groups exhibited significant reductions in serum total bile acid (TBA), total bilirubin (TBIL), and direct bilirubin (DBIL) levels (P<0.05), with the study group showing greater improvements. The study group also displayed a significantly lower transcutaneous bilirubin index over five days of treatment, indicating a faster decrease in jaundice severity (P<0.05). The onset of treatment effects and the resolution of jaundice were quicker in the study group, and the incidence of adverse reactions was lower compared to the control group (7.78% vs. 18.89%, P<0.05). Conclusion: Bifidobacterium triple viable adjuvant treatment significantly enhances the management of neonatal jaundice, promoting faster recovery and reducing adverse reactions. By potentially mitigating early-life stressors associated with neonatal jaundice, this approach may have positive implications for long-term mental and physical health, potentially influencing future resilience and performance in athletic contexts, underscoring the importance of considering gut health in neonatal care strategies